Mark Dershwitz, M.D., Ph.D.

Academic Role: Professor

Faculty Appointment(s) and Affiliations:
T.H. Chan School of Medicine
   Anesthesiology
Biochemistry and Molecular Pharmacology
Morningside Graduate School of Biomedical Sciences
Millennium PhD Graduate Program

Clinical Interests: Vascular Anesthesia, Pharmacology, Education

Phone:  (508) 856-2480
Email: mark.dershwitz@umassmed.edu

Academic Background

Ph.D. (Pharmacology) Northwestern University, 1982
M.D. Northwestern University, 1982

Postdoctoral Training

Massachusetts General Hospital, Residency in Anesthesiology, 1984-1986
Massachusetts General Hospital, Research Fellowship in Anesthesiology, 1986-1988

Selected Publications

Cooper JB, Blum RH, Carroll JS, Dershwitz M, Feinstein DM, Gaba DM, Morey JC, Singla AK.  Differences in safety climate among hospital anesthesia departments and the effect of a realistic simulation-based training program.  Anesth Analg 2008; 106:574-84.

Dershwitz M.   Is droperidol safe?   Probably...  Semin Anesth Periop Med Pain 2004; 23:291-301.

Dershwitz M.   Droperidol:   should the black box be light gray?   J Clin Anesth 2002; 14:598-603.

Dershwitz M, Michałowski P, Chang YC, Rosow CE, Conlay LA.  Postoperative nausea and vomiting following total intravenous anesthesia with propofol and remifentanil or alfentanil.  How important is the opioid?  J Clin Anesth 2002; 14:275-78.

Dershwitz M, Walsh JL, Morishige RJ, Connors PM, Rubsamen RM, Shafer, SL, Rosow C.   Pharmacokinetics and pharmacodynamics of inhaled versus intravenous morphine in healthy volunteers.  Anesthesiology 2000; 93:619-28.

Dershwitz M, Conant JA, Chang YC, Rosow CE, Connors PM.   A randomized double-blind dose-response study of ondansetron in the prevention of postoperative nausea and vomiting. J Clin Anesth 1998; 10:314-20.

Kearse LA, Rosow C, Zaslavsky A, Connors P, Dershwitz M, Denman W.  Bispectral analysis of the electroencephalogram predicts conscious processing of information during propofol sedation and hypnosis.  Anesthesiology 1998; 88:25-34.

Hoke JF, Shlugman D, Dershwitz M, Michałowski P, Malthouse-Dufore S, Connors PM, Marten D, Rosow CE, Muir KT, Rubin N, Glass PSA.   Pharmacokinetics and pharmacodynamics of remifentanil in subjects with renal failure compared to healthy volunteers.   Anesthesiology 1997; 87:533-41.

Dershwitz M, Hoke JF, Rosow CE, Michałowski P, Connors PM, Muir KT, Dienstag JL.   Pharmacokinetics and pharmacodynamics of remifentanil in volunteer subjects with severe liver disease.   Anesthesiology 1996; 84:812-20.

Dershwitz M, Randel GI, Rosow CE, Fragen RJ, Connors PM, Librojo ES, Shaw DL, Peng AW, Jamerson BD.   Initial clinical experience with remifentanil, a new opioid metabolized by esterases.   Anesth Analg 1995; 81:619-23.

Dershwitz M, Di Biase PM, Rosow CE, Wilson RS, Sanderson PE, Joslyn AF.   Ondansetron does not affect alfentanil-induced ventilatory depression or sedation.   Anesthesiology 1992; 77:447-52.

Dershwitz M, Rosow CE, Di Biase PM, Joslyn AF, Sanderson PE.   Ondansetron is effective in decreasing postoperative nausea and vomiting.   Clin Pharmacol Ther 1992; 52:96-101.

Dershwitz M, Rosow CE, Di Biase PM, Zaslavsky A.   Comparison of the sedative effects of butorphanol and midazolam.   Anesthesiology 1991; 74:717-24.